SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLASs REGAL Phase 3 trial reaching its 80-event threshold has shifted attention to the upcoming GPS survival-data readout after database lock and final analysis. Traders are sharply divided: bulls expect a meaningful survival benefit, while skeptics question the trials dosing changes, control-arm outcomes and whether the results will support approval.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazons quarterly results put the spotlight on strong AWS growth but also heavy AI infrastructure spending and a sharp free-cash-flow swing, stoking concerns about when the investment will pay off. Traders are split between questioning the cash burn and buying the post-earnings selloff, with many pointing to a sharp rebound as evidence of dip-buying support.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantirs upcoming Q3 earnings report is the main focus, with traders looking beyond a potential beat to whether guidance can sustain its AI growth story amid a broader pullback in tech stocks. Bulls expect strong results and a raised outlook, while bears argue the valuation leaves little room for an ordinary quarter or disappointing guidance.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovins steep selloff ahead of its upcoming earnings report is driving attention, with traders weighing concerns about advertising demand, competition and weakness across ad-tech and software stocks. Bulls argue the decline has outpaced the companys fundamentals and are buying the dip, while bears fear the report or outlook could validate further downside.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Inovios FDA accelerated approval of Voceryq, a competing treatment for recurrent respiratory papillomatosis, has raised concerns about competition for Precigens Papzimeos. Traders debate whether Voceryqs surgery-free dosing will erode demand or whether Papzimeos can retain an advantage through its commercial head start, established payer access, and full approval.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPaths post-earnings selloff and analyst downgrades following its Investor Day are driving discussion, with traders focused on skepticism about slowing growth and whether its agentic-AI push can translate into stronger revenue. Bulls view the companys orchestration products, cash position, and enterprise potential as undervalued, while bears say the business still needs to prove the strategy commercially.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

A third-party photo and commentary identifying POET hardware in Foxconns photonics ecosystem has renewed attention to the FIT collaboration, with traders treating it as validation while debating whether it could lead to production orders; POET has not confirmed new orders. Traders are also weighing reported MarvellLumentum acquisition talks, speculating that optics-sector consolidation could benefit POET as an independent supplier, though others see potential competitive or supply-chain risks.

Invesco DB US Dollar Index Bullish Fund - Invesco DB US Dollar Index Bullish Fund

Invesco DB US Dollar Index Bullish Fund

Shifting expectations for Fed policy and U.S. interest rates are driving discussion of the dollars moves against major currencies. Traders are split between seeing higher yields and rate-hike bets as support for UUP and warning that fiscal concerns and dollar weakness could undermine the trend.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPals Q3 results are driving attention: adjusted earnings beat expectations and full-year guidance rose, while revenue missed and growth remained modest. Traders are split between viewing cash flow and buybacks as support and worrying that weak branded-checkout growth and margin pressure undermine the turnaround; takeover and bank-charter chatter remains speculative.

Datadog, Inc. engages in the development of a monitoring and analytics platform for developers, information technology operations teams and business users. Its platform integrates and automates infrastructure monitoring, application performance monitoring and log management to provide real-time observability of its customers' entire technology stack. The company was founded by Olivier Pomel and Alexis Lê-Quôc on June 4, 2010 and is headquartered in New York, NY.

Datadog Inc - Ordinary Shares - Class A

Datadog Inc

Datadog is drawing attention after a sharp pullback amid weakness in software stocks, with traders citing its rich valuation and positioning ahead of the upcoming earnings report. Some view the drop as a buying opportunity and point to call activity, while others expect further downside; no company-specific catalyst is clearly established.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bio-Techne Expands Global GMP Manufacturing Network with New Bristol Facility to Advance Scalable Cell Therapy Development

Bio-Techne Expands Global GMP Manufacturing Network with New Bristol Facility to Advance Scalable Cell Therapy Development Bio-Techne Expands Global GMP Manufacturing Network with New Bristol Facility to Advance Scalable Cell Therapy DevelopmentPR NewswireMINNEAPOLIS, Oct. 8, 2026Investment...

Insider Activity Update: John L Higgins Executes Options Exercise, Resulting In $751K At Bio-Techne

On September 30, it was revealed in an SEC filing that John L Higgins, Director at Bio-Techne (NASDAQ:TECH) executed a significant exercise of company stock options.
What Happened: A Form 4 filing with the U.S.read more...

INCY or TECH: Which Is the Better Value Stock Right Now?

INCY vs. TECH: Which Stock Is the Better Value Option?

Robert V Baumgartner Exercises Options, Realizes $754K

Robert V Baumgartner, Board Member at Bio-Techne (NASDAQ:TECH), reported a large exercise of company stock options on September 24, according to a new SEC filing.
What Happened: In an insider options exercise disclosedread more...

Bio-Techne Shareholders Approve Merck KGaA Acquisition Plan

(RTTNews) - Wednesday, Bio-Techne Corp. (TECH) announced that its shareholders have approved the acquisition of the company by Merck KGaA (MKKGY.PK), Darmstadt, Germany, marking an important milestone toward completing the transaction...

Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany

Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, GermanyPR NewswireMINNEAPOLIS, Sept. 23, 2026 MINNEAPOLIS, Sept. 23, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) ("Bio-Techne"), a...

Bio-Techne Opens New Customer Experience Center in Dsseldorf to Accelerate Scientific Discovery and Customer Collaboration

Bio-Techne Opens New Customer Experience Center in Dsseldorf to Accelerate Scientific Discovery and Customer Collaboration Bio-Techne Opens New Customer Experience Center in Dsseldorf to Accelerate Scientific Discovery and Customer CollaborationPR NewswireMINNEAPOLIS and DSSELDORF, Germany, Sept...

Why Is Techne (TECH) Down 0.1% Since Last Earnings Report?

Techne (TECH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Looming Merger Shareholder Vote - AUUD, TECH, CZR and CBAN

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Looming Merger Shareholder Vote - AUUD, TECH, CZR and CBAN $HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Looming Merger Shareholder Vote - AUUD, TECH, CZR and CBAN PR Newswire NEW YORK, Sept. 10, 2026 NEW YORK, Sept. 10...

Are FULC, WEAV, TECH Obtaining Fair Deals for their Shareholders?

Are FULC, WEAV, TECH Obtaining Fair Deals for their Shareholders? Are FULC, WEAV, TECH Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, Sept. 9, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may...

Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. The firm's products assist scientific investigations into biological processes and the nature and progress of specific diseases. It operates through the Protein Sciences and Diagnostics and Spatial Biology segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN.

Bio-Techne Corp

Are AMZN Shares Poised For A 9-Day Losing Streak? Here’s What Retail Thinks

Equity

Bullish Sentiment

<ul class="summary-bullets"><li>One bullish user on Stocktwits said they have not seen Amazon shares being this cheap on a price-to-earnings ratio in at least the last decade.&nbsp;</li><li>In its latest earnings results, Amazon said it would boost its capital expenditure for 2026 to $200 billion, up from about $130 billion reported in 2025.</li></ul>Amazon.com (AMZN) shares are poised for a ninth straight day of losses as concerns over the tech giant’s sharply higher capital spend planned for 2026 rise among investors.AMZN shares reversed to green, climbing 0.27% higher on Friday at the time of writing, after having declined about 0.7% earlier in the day.The stock has lost about 17.5% of its value in the last month, even as the company’s shares hover near their lowest level since May 23, 2025, when they opened at $198.90.<figure class="image"><img src="https://news.stocktwits-cdn.com/koyfin_20260213_095554045_png_8173413ba0.webp" alt="koyfin_20260213_095554045.png" width="2400" height="1240"><figcaption>Amazon Share Price | Source: Koyfin</figcaption></figure>On Stocktwits, retail sentiment around the stock has fallen in the past 24 hours, dropping from the ‘extremely bullish’ to ‘bullish’ territory at the time of writing. Meanwhile, retail chatter has jumped about 35% in the same period, according to Stocktwits data from Friday morning.<h2 class="st-heading-2">What Are Stocktwits Users Saying?</h2>One user on Stocktwits said that AMZN shares would trade higher after the soft January inflation report. The user said that lower rates were on the horizon on an ‘already completely over sold stock.’<stembedurl>https://stocktwits.com/Boardroommaster/message/644937046</stembedurl>&nbsp;Another bullish user said they have not seen Amazon shares being this cheap on a price-to-earnings ratio in at least the last decade.<stembedurl>https://stocktwits.com/America_First_Home_Loans/message/644917841</stembedurl>&nbsp;However, one user warned of more declines, including another dip next week, adding that the company would likely not breach $240 for another three to four months.<stembedurl>https://stocktwits.com/Snackdaddy/message/644876060</stembedurl>&nbsp;Another bullish user said that now would be the best time to buy a mega cap stock amid pullbacks, forecasting that AMZN shares would soar past $300 in the next six to 12 months.<stembedurl>https://stocktwits.com/What_Are_Stocks_2/message/644928956</stembedurl><h2 class="st-heading-2">&nbsp;</h2><h2 class="st-heading-2">Capital Spend</h2>In its latest <a href="https://stocktwits.com/news-articles/markets/equity/amazon-q4-2025-revenue-beats-estimates-on-strong-aws-results-announces-200b-capital-spending-in-2026/cZbZl9hR4n3">earnings results</a>, Amazon said it would boost its capital expenditure for 2026 to $200 billion, up from about $130 billion reported in 2025.This is in line with other large tech companies that have collectively announced plans to invest over $630 billion in AI buildouts in 2026, more than double the spend from 2025.Andy Jassy, President and CEO of Amazon, told investors that the capital expenditures would predominantly be in Amazon Web Services because of “very high demand,” adding that the company anticipated “strong long-term return on invested capital.”While investors have largely expressed concerns over the massive expenditures on AI by the tech companies, leaders have actively backed the plan. CEO of Nvidia Corp. (NVDA) Jensen Huang said earlier this month that these investments are “appropriate and sustainable,” noting that the demand for AI is now skyrocketing.Meanwhile, <a href="https://stocktwits.com/symbol/AMZN">shares of AMZN</a> have declined by over 13% in the past year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

The logo and lettering of Amazon can be seen on the facade of Amazon Germany's headquarters in Parkstadt Schwabing in Munich (Bavaria). (Photo by Matthias Balk/picture alliance via Getty Images)

Amazon.com stock has lost about 17.5% of its value in the last one month, even as the company’s shares hover near their lowest level since May 23, 2025.

Roundhill Magnificent Seven ETF

Vanguard Consumer Discretionary ETF

Vanguard Total Stock Market ETF

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$72.66
Prev Close	$72.71
Open	$72.69
Dividend Yield	0.45%
50-Day Moving Average	$72.45
Beta	1.09
Avg. Volume	3.09M
PE Ratio	62.72

52-Week High	$72.75
52-Week Low	$43.20
Market Capitalization	$11.41B
EPS (Annual)	$1.16
Price to Book	5.38
Revenue Per Employee	$405,013.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

TECH Fundamentals